Darwin Biosciences
Disease Detection Simplified
About
Darwin Biosciences is redefining how infected individuals are detected by measuring an early immune response in saliva. Our hand-held device, developed in collaboration with the US Department of Defense and academic institutions, amplifies and detects human RNA in saliva that is broadly indicative of infection at the pre-symptomatic, asymptomatic, and symptomatic stages.
Founders
- Nicholas Meyerson — Co-Founder and CEO
- Qing Yang — Co-Founder & Scientific Consultant
Key features
Technologies
Investors
News
- Building Darwin Biosciences: 5 years of innovation and challenges · 2025-03-06T00:00:00.000Z
- Kyle Clark - Device Engineer | Diagnostic Platform Development · 2026-02-15T00:00:00.000Z
- Get a front-row seat to the University of Colorado's next big ideas ... · 2025-09-24T00:00:00.000Z
- Colorado BioScience Association Strengthens Board Leadership to ... · 2026-03-04T00:00:00.000Z
- Darwin AG | · 2026-03-18T10:00:04.000Z
Browse similar startups
Related startups
- Grasshopper Health — Denver, CO
- Health Studio LLC — Wheat Ridge, CO
- Healthcare Data Analytics, Inc. — Aspen, CO
- Orbit Genomics — Boulder, CO
- PulseMedAI, LLC — Golden, CO
- SALIDA DERMATOLOGY — Salida, CO
- DataVibe Analytics LLC — Fort Lauderdale, FL
- DB Diagnostics — Nashville, TN
- Decatur Pediatric Group — Clarkston, GA
- Definitive Diagnostics, Inc. — St. Louis, MO
- dentalrobot®, AI RCM, Voice and Workflow Orchestration for Dental Support Organizations — Doral, FL
- DentiScope Inc. — Boston, MA
Profile updated Jul 29, 2026. Sources: darwin.bio


